Personalized Cancer Care: From Testing to Application
Peter Paul Yu, MD, FACP, FASCO, is a medical oncologist and haematologist and Director of Cancer Research at Palo Alto Medical Foundation, where he worked since 1989. In addition to his role as the 2014-2015 President of ASCO, Dr. Yu also serves on the Scientific Program, Nominating, Government Relations, and Special Awards Selection Committees. Since joining ASCO in 1986, Dr. Yu has served on the Quality of Care Committee, Strategic Planning Committee, Integrated Media and Technology Committee, Board of Directors, and Cancer Research Committee, among others. He has served as Chair of the Health Information Technology Workgroup, Clinical Practice Committee, and Best of ASCO Planning Committee, and as President of the Association of Northern California Oncologists (ANCO; an ASCO State/Regional Affiliate society). He was Co-Chair of the ASCO-NCI Clinical Oncology Requirements for the EHR Committee (2008). He is currently a columnist on ASCOconnection.org. In addition to his ASCO involvement, Dr. Yu is a member of the Cancer and Leukemia Group B as well as the Gynecologic Oncology Group. He is a Co-Chair of the Commission for the Certification of Health Information Technology Workgroups on Research and Oncology. Dr. Yu received his medical degree from Brown University, and performed his internship and residency in Internal Medicine at St. Luke’s-Roosevelt Hospital and a fellowship in neoplastic diseases at Mount Sinai Hospital. He was a Research Fellow and Associate at Memorial Sloan Kettering Cancer Center.